Aligos Therapeutics, Inc. (ALGS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.56
Day's range
$7.3

Aligos Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DEEP TRACK CAPITAL, LP 05/15/2026 444.11 K $3.30 M   0.00% 4.49%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 412.00 K $3.06 M   0.00% 4.17%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 327.24 K $2.43 M   -2.59% 3.31%
MARSHALL WACE, LLP 05/15/2026 267.14 K $1.98 M   -0.57% 2.70%
BANK OF AMERICA CORP /DE/ 05/18/2026 229.75 K $1.71 M   1,652.78% 2.32%
05/15/2026 178.26 K $1.32 M   100.00% 1.80%
WOODLINE PARTNERS LP 05/15/2026 177.36 K $1.32 M   -38.66% 1.79%
SUMMITTX CAPITAL, L.P. 05/15/2026 148.80 K $1.11 M   6.72% 1.51%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 100.45 K $746.34 K   17.56% 1.02%
BAKER BROS. ADVISORS LP 05/15/2026 83.06 K $617.10 K   0.00% 0.84%
HHLR ADVISORS, LTD. 05/15/2026 76.25 K $566.52 K   0.00% 0.77%
CITADEL ADVISORS LLC 05/15/2026 54.31 K $403.53 K   4.78% 0.55%
LPL FINANCIAL LLC 05/06/2026 51.50 K $382.65 K   -21.97% 0.52%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 49.98 K $371.47 K   4.68% 0.51%
UBS GROUP AG 05/05/2026 37.06 K $275.36 K   10,081.59% 0.37%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 28.44 K $211.29 K   100.00% 0.29%
TWO SIGMA INVESTMENTS, LP 05/15/2026 23.09 K $171.58 K   -71.37% 0.23%
VERITION FUND MANAGEMENT LLC 05/15/2026 18.89 K $140.33 K   -73.49% 0.19%
XTX TOPCO LTD 05/15/2026 14.20 K $105.48 K   -38.42% 0.14%
BLACKROCK, INC. 05/13/2026 13.04 K $96.89 K   0.00% 0.13%
D. E. SHAW & CO., INC. 05/15/2026 10.98 K $81.57 K   100.00% 0.11%
QUADRATURE CAPITAL LTD 05/15/2026 10.82 K $80.41 K   100.00% 0.11%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/14/2026 10.00 K $74.30 K   0.00% 0.10%
GOLDEN STATE WEALTH MANAGEMENT, LLC 04/28/2026 2.67 K $19.87 K   0.00% 0.03%
ROYAL BANK OF CANADA 05/15/2026 2.13 K $16.00 K   0.00% 0.02%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 05/14/2026 950 $7.06 K   100.00% 0.01%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 936 $6.95 K   100.00% 0.01%
WELLS FARGO & COMPANY/MN 05/11/2026 700 $5.20 K   -53.33% 0.01%
JPMORGAN CHASE & CO 05/13/2026 674 $4.42 K   120.26% 0.01%
MORGAN STANLEY 05/15/2026 218 $1.62 K   -91.35% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 65 $483   66.67% 0.00%
SBI SECURITIES CO., LTD. 04/28/2026 26 $193   0.00% 0.00%
ZRC WEALTH MANAGEMENT, LLC 04/14/2026 4 $30   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 3 $22   0.00% 0.00%
FMR LLC 05/15/2026 0 $0   -100.00% 0.00%
CITIGROUP INC 05/11/2026 0 $0   -100.00% 0.00%
HRT FINANCIAL LP 05/14/2026 0 $0   -100.00% 0.00%
DRW SECURITIES, LLC 05/13/2026 0 $0   -100.00% 0.00%
CLEAR STREET MARKETS LLC 04/30/2026 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 05/12/2026 0 $0   -100.00% 0.00%
NORTHCREST ASSET MANANGEMENT, LLC 04/08/2026 0 $0   -100.00% 0.00%

Aligos Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 49 institutional investors and hedge funds held shares of Aligos Therapeutics Inc. The most heavily invested institutionals were:

Deep Track Capital, LP: 444,110

Alyeska Investment Group, L.P.: 412,000

Sio Capital Management, LLC: 327,237

MARSHALL WACE, LLP: 267,135

BANK OF AMERICA CORP /DE/: 229,754

Woodline Partners LP: 177,362

28.07% of Aligos Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 6.09 M shares in the last 24 months. This purchase volume represents approximately $42.84 M in transactions.